A lecturer from the Department of Life Sciences publishes scientific research on the relationship between levels of harmful fats (LDL) and the PCSK9 protein in patients with coronary artery disease.
A lecturer from the Department of Life Sciences publishes scientific research on the relationship between levels of harmful fats (LDL) and the PCSK9 protein in patients with coronary artery disease.
Publishing scientific research
A lecturer in the Department of Biology and assistant Lecturer (Zulfiqar Abbas Miteb) in the College of Education for Science/University of Karbala, published a research entitled (The relationship between levels of harmful fats (LDL) and the PCSK9 protein in patients with coronary artery disease in patients hospitalized in the Holy Karbala Governorate). It was published in an international magazine (World of Science: Journal on Modern Research Methodologies), which is published by Universal Publishing Press in the United States of America. This research aims to examine whether circulating levels of PCSK9 are associated with LDL subsets. It also included measuring 70 patients suffering from coronary artery disease. Levels of PCSK9, LDL, and 30 healthy controls were measured. The results were that 80% of patients were men, with an average age between 40 and 70 years. Patients showed increasingly higher PCSK9 levels compared to the control group of 30 males. Serum PCSK9 levels were associated with CM treatment in patients, while NCM had the opposite effect. Patients whose PCSK9 levels were above average showed a significant increase.
A lecturer from the Department of Life Sciences publishes scientific research on the relationship between levels of harmful fats (LDL) and the PCSK9 protein in patients with coronary artery disease.
A lecturer in the Department of Biology and assistant Lecturer (Zulfiqar Abbas Miteb) in the College of Education for Science/University of Karbala, published a research entitled (The relationship between levels of harmful fats (LDL) and the PCSK9 protein in patients with coronary artery disease in patients hospitalized in the Holy Karbala Governorate). It was published in an international magazine (World of Science: Journal on Modern Research Methodologies), which is published by Universal Publishing Press in the United States of America. This research aims to examine whether circulating levels of PCSK9 are associated with LDL subsets. It also included measuring 70 patients suffering from coronary artery disease. Levels of PCSK9, LDL, and 30 healthy controls were measured. The results were that 80% of patients were men, with an average age between 40 and 70 years. Patients showed increasingly higher PCSK9 levels compared to the control group of 30 males. Serum PCSK9 levels were associated with CM treatment in patients, while NCM had the opposite effect. Patients whose PCSK9 levels were above average showed a significant increase.
